| Natural products as aromatase inhibitors MJ Balunas, B Su, RW Brueggemeier, AD Kinghorn Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal …, 2008 | 147 | 2008 |
| Xanthones from the Botanical Dietary Supplement Mangosteen (Garcinia mangostana) with Aromatase Inhibitory Activity MJ Balunas, B Su, RW Brueggemeier, AD Kinghorn Journal of natural products 71 (7), 1161-1166, 2008 | 138 | 2008 |
| From COX-2 inhibitor nimesulide to potent anti-cancer agent: synthesis, in vitro, in vivo and pharmacokinetic evaluation B Zhong, X Cai, S Chennamaneni, X Yi, L Liu, JJ Pink, A Dowlati, Y Xu, ... European journal of medicinal chemistry 47, 432-444, 2012 | 72 | 2012 |
| Novel sulfonanilide analogues suppress aromatase expression and activity in breast cancer cells independent of COX-2 inhibition B Su, ES Diaz-Cruz, S Landini, RW Brueggemeier Journal of medicinal chemistry 49 (4), 1413-1419, 2006 | 62 | 2006 |
| COX inhibitors Indomethacin and Sulindac derivatives as antiproliferative agents: synthesis, biological evaluation, and mechanism investigation S Chennamaneni, B Zhong, R Lama, B Su European journal of medicinal chemistry 56, 17-29, 2012 | 61 | 2012 |
| Synthesis and characterization of azole isoflavone inhibitors of aromatase JC Hackett, YW Kim, B Su, RW Brueggemeier Bioorganic & medicinal chemistry 13 (12), 4063-4070, 2005 | 54 | 2005 |
| A COX-2 inhibitor nimesulide analog selectively induces apoptosis in Her2 overexpressing breast cancer cells via cytochrome c dependent mechanisms B Chen, B Su, S Chen Biochemical pharmacology 77 (12), 1787-1794, 2009 | 53 | 2009 |
| Synthesis and biological evaluation of selective aromatase expression regulators in breast cancer cells B Su, S Landini, DD Davis, RW Brueggemeier Journal of medicinal chemistry 50 (7), 1635-1644, 2007 | 50 | 2007 |
| Development, validation and pilot screening of an in vitro multi-cellular three-dimensional cancer spheroid assay for anti-cancer drug testing R Lama, L Zhang, JM Naim, J Williams, A Zhou, B Su Bioorganic & medicinal chemistry 21 (4), 922-931, 2013 | 48 | 2013 |
| Growth factor signaling enhances aromatase activity of breast cancer cells via post-transcriptional mechanisms B Su, C Wong, Y Hong, S Chen The Journal of steroid biochemistry and molecular biology 123 (3-5), 101-108, 2011 | 46 | 2011 |
| Aromatase and COX in breast cancer: enzyme inhibitors and beyond RW Brueggemeier, B Su, Y Sugimoto, ES Díaz-Cruz, DD Davis The Journal of steroid biochemistry and molecular biology 106 (1-5), 16-23, 2007 | 42 | 2007 |
| Synthesis and biological evaluation of thiabendazole derivatives as anti-angiogenesis and vascular disrupting agents C Zhang, B Zhong, S Yang, L Pan, S Yu, Z Li, S Li, B Su, X Meng Bioorganic & Medicinal Chemistry 23 (13), 3774-3780, 2015 | 40 | 2015 |
| Synthesis and biological evaluation of novel sulfonanilide compounds as antiproliferative agents for breast cancer B Su, MV Darby, RW Brueggemeier Journal of combinatorial chemistry 10 (3), 475-483, 2008 | 37 | 2008 |
| Novel sulfonanilide analogs decrease aromatase activity in breast cancer cells: synthesis, biological evaluation, and ligand-based pharmacophore identification B Su, R Tian, MV Darby, RW Brueggemeier Journal of medicinal chemistry 51 (5), 1126-1135, 2008 | 37 | 2008 |
| Suppression of aromatase in human breast cells by a cyclooxygenase-2 inhibitor and its analog involves multiple mechanisms independent of cyclooxygenase-2 inhibition B Su, ES Díaz-Cruz, S Landini, RW Brueggemeier Steroids 73 (1), 104-111, 2008 | 37 | 2008 |
| Synthesis and anticancer mechanism investigation of dual Hsp27 and tubulin inhibitors B Zhong, S Chennamaneni, R Lama, X Yi, WJ Geldenhuys, JJ Pink, ... Journal of Medicinal Chemistry 56 (13), 5306-5320, 2013 | 36 | 2013 |
| Identification of a class of novel tubulin inhibitors X Yi, B Zhong, KM Smith, WJ Geldenhuys, Y Feng, JJ Pink, A Dowlati, ... Journal of medicinal chemistry 55 (7), 3425-3435, 2012 | 33 | 2012 |
| Lead optimization of COX-2 inhibitor nimesulide analogs to overcome aromatase inhibitor resistance in breast cancer cells B Su, S Chen Bioorganic & medicinal chemistry letters 19 (23), 6733-6735, 2009 | 33 | 2009 |
| Lead optimization of 7-benzyloxy 2-(4′-pyridylmethyl) thio isoflavone aromatase inhibitors B Su, JC Hackett, ES Díaz-Cruz, YW Kim, RW Brueggemeier Bioorganic & medicinal chemistry 13 (23), 6571-6577, 2005 | 32 | 2005 |
| Design and synthesis of small molecule agonists of EphA2 receptor A Petty, N Idippily, V Bobba, WJ Geldenhuys, B Zhong, B Su, B Wang European journal of medicinal chemistry 143, 1261-1276, 2018 | 31 | 2018 |
